A randomized controlled clinical study to evaluate the efficacy of Vari vidaryadi Kashaya in the management of Pittaja Mutrakrichra
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- To evaluate the efficacy of Vari vidaryadi kashaya in the management of pittaja mutrakrichra
Study Overview
Brief Summary
The study is randomized parallel group actively controlled comparative clinical study with Haritakyadi kashaya as standard drug and Vari vidaryadi kashaya as interventional drug which is given orally in the dosage of average 10 ml twice a day before food for a period of 7 days
The study will be conducted on subjects having pittaja mutrakrichra belonging to the age group of 6 to 16 years who has given written and verbal consent by parents for undergoing clinical study
The study will be conducting in Alvas Ayurveda Medical College and Hospital Moodubidire
Interventional period of the study is 14 days and assessment will be done before treatment, on 3rd, 7th and 14th day
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 6.00 Year(s) to 16.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients irrespective of sex between age group of 6 to 16 years Patients fulfilling the diagnostic criteria of Pittaja Mutrakrichra Symptoms less than 1 week duration.
Exclusion Criteria
- •A child having UTI associated with surgical intervention and instrumentation Child who is not accepting orally and suffering with any serious systemic illness eg septicemia meningitis severe dehydration shock persistent vomiting severe abdominal pain fever Recurrent UTI with congenital kidney diseases pyelonephritis renal failure hematuria nephrotic syndrome vesicouteric reflex enuresis phimosis.
Outcomes
Primary Outcomes
To evaluate the efficacy of Vari vidaryadi kashaya in the management of pittaja mutrakrichra
Time Frame: Before treatment | on 3rd day | on 7th day | on 14th day
Secondary Outcomes
- Objective parameters are assessed(Pus cells/ hpf)
Investigators
Dr Arsha KP
Alvas Ayurveda Medical College and Hospital